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B A C K G R O U N D :  India’s Revised National Tuberculosis 
Control Programme (RNTCP) recommends screening 
of all household contacts of smear-positive pulmonary 
tuberculosis (PTB) cases for tuberculosis (TB) disease, 
and 6-month isoniazid preventive therapy (IPT) for 
a symptomatic children aged <6 years.
O B J E C T I V E :  To assess the implementation of child 
contact screening and IPT administration under the 
RNTCP.
M E T H O D S :  A cross-sectional study conducted in four 
randomly selected TB units (TUs), two in an urban 
(Chennai City) and two in a rural (Vellore District) area 
of Tamil Nadu, South India, from July to September 
2008. The study involved the perusal of TB treatment 
cards of source cases (new or retreatment smear-positive 
PTB patients started on treatment), interview of source 
cases and focus group discussions (FGDs) among health 
care workers.
R E S U LT S :  Interviews of 253 PTB patients revealed that 
of 220 contacts aged <14 years, only 31 (14%) had 
been screened for TB, and that of 84 household children 
aged <6 years, only 16 (19%) had been initiated on IPT. 
The treatment cards of source cases lacked documenta-
tion of contact details. FGDs revealed greater TB aware-
ness among urban health care workers, but a lack of de-
tailed knowledge about procedures. 
C O N C L U S I O N :  Provision for documentation using a sep-
arate IPT card and focused training may help improve 
the implementation of contact screening and IPT.
K E Y  W O R D S :  contact screening; IPT; RNTCP; chemo-
prophylaxis; children
EACH YEAR about 1 million cases (11%) of tuber-
culosis (TB) are estimated to occur in children aged 
<15 years, with the 22 high-burden TB countries 
contributing 75% of these cases.1 The source of in-
fection for most children is an infectious adult in 
close proximity (usually the household). The concen-
tration of bacilli in the sputum of a person with TB 
correlates highly with the infectivity of that person.2 
Studies have highlighted high rates of infection and 
disease among child contacts of adults with sputum 
positive pulmonary TB (PTB).3,4 
India’s Revised National TB Control Programme 
(RNTCP) recommends screening of all household con-
tacts of smear-positive PTB cases, especially those aged 
<6 years, for symptoms of TB.5 For asymptomatic 
children and those found not to be suffering from TB 
disease, daily isoniazid preventive treatment (IPT) at 
5 mg/kg is recommended for 6 months.5 To ensure 
that proper preventive chemotherapy is given to chil-
dren, the Medical Offi cer should ask (or have the 
health workers ask) all smear-positive PTB patients if 
they have children aged <6 years and ensure that they 
S U M M A R Y
are brought to a health unit for screening. On the re-
verse side of the RNTCP TB treatment card, the num-
ber of household contacts (children aged <6 years) 
and the number of contacts placed on IPT can be 
recorded.
A study was conducted to assess the implementa-
tion of contact screening and IPT under the RNTCP. 
The awareness of and barriers to child contact man-
agement among health care workers and PTB patients 
were also studied.
METHODOLOGY
A cross-sectional study was conducted in four TB 
units (TU), two in an urban (Chennai City) and two 
in a rural (Vellore District) area* of Tamil Nadu, 
which were selected by simple random sampling tech-
nique. A source case was defi ned as a new or retreat-
ment smear-positive PTB patient who had been started 
* Under the RNTCP, a TU is a subdistrict supervisory unit that 
covers a population of, on average, 500 000.
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that the mouth should be covered while coughing 
was respectively 73% and 92%. The knowledge that 
TB is transmissible to other family members was sig-
nifi cantly lower among rural than urban patients (25/ 
118, 21% vs. 113/135, 84%, P < 0.001).
The information obtained on contact screening 
and IPT initiation is shown in Table 2. Among the 
220 contacts aged 0–14 years, only 31 (14%) had been 
screened for TB disease. None of the child contacts 
screened was diagnosed with active TB disease. Of 
the 55 patients who had children aged <6 years, only 
15 (27%) stated that they had been informed about 
the provision of IPT for their children. Among chil-
dren aged <6 years, only 16 (19%) had been initi-
ated on IPT, with no difference between rural and ur-
ban groups. In these cases, isoniazid (INH) was given 
to the source case as a monthly supply to be given to 
the child contact, and there was no follow-up of the 
child initiated on IPT. According to the patients, these 
children did not experience side effects with INH.
The treatment cards of 253 source cases contained 
no documentation of the number of children aged 
<6 years residing in the household, nor of those 
screened for TB. IPT initiation was recorded for all 
16 children initiated on IPT. There was, however, no 
documentation of screening, follow-up, drug supply 
or treatment completion for these children. 
on treatment during the period from April to June 
2008.
TB treatment registers and individual TB treatment 
cards were perused for documentation on contact 
screening and IPT. Awareness about RNTCP contact 
screening and IPT policies among source cases was 
studied by an interview conducted in the local lan-
guage (Tamil) by trained fi eld investigators using a 
semi-structured interview schedule. This contained 
ques tions on the duration of symptoms, awareness 
of risk of transmission to family contacts, number of 
close contacts—especially children aged <6 years, 
screening for TB among children aged 0–14 years by 
symptom elucidation and relevant investigations (chest 
X-ray, sputum examination), initiation of chemo-
prophylaxis, and treatment adherence and completion. 
There is currently no provision for documentation of 
the details of contact screening, IPT administration 
and follow-up, and these details therefore could not 
be elicited from the TB treatment card of the source 
case. The patient interview was thus considered as 
the most reliable source of information. Four focus 
group discussions (FGDs), one at each site, were 
conducted among health care workers (HCWs) in Ta-
mil by a facilitator. These included Medical Offi cers 
(MOs), senior TB treatment supervisors (STS), TB 
health visitors and village health nurses (VHNs) in-
volved in administering treatment. There were about 
10 participants in each focus group. Discussions fo-
cused on issues related to RNTCP policy on contact 
management and IPT, and the diffi culties encountered 
in implementation. The responses were recorded and 
later transcribed.
The study was approved by the Institutional Eth-
ics Committee of the Indian Council of Medical Re-
search, and informed consent was obtained from pa-
tients and HCWs before interviews/discussions. Data 
were double entered and analysed using SPSS V13.0 
(Statistical Package for the Social Sciences, Chicago, 
IL, USA). FGD analysis identifi ed issues around the 
key discussion topics. 
RESULTS
Among the 370 registered source cases, 32 (9%) de-
faulted, 7 (2%) died, 7 (2%) transferred out and 5 
(1%) migrated. Of the remaining 319 patients, 253 
were interviewed. Their profi le is shown in Table 1. 
There were 118 (47%) patients from the rural and 
135 (53%) patients from the urban study sites. There 
were 191 (75%) males, 202 (80%) new smear-positive 
PTB patients on Category 1 treatment, and 110 (43%) 
patients were aged between 26–45 years. The dura-
tion of symptoms before diagnosis was <4 weeks in 
134 (53%) patients; this was signifi cantly higher 
among urban than rural patients (88/135, 65% vs. 
46/118, 39%, P < 0.01). Overall awareness that the 
mode of transmission is by the airborne route and 
Table 1 Proﬁ le of 253 interviewed smear-positive PTB 
patients and awareness of TB transmission
Characteristics
Rural
(n = 118)
n (%)
Urban
(n = 135)
n (%)
Total
(N = 253)
n (%)
Male sex 88 (75) 103 (76) 191 (75)
Age, years 
 ⩾15–25
 26–35
 36–45
 46–65
 >65
16 (14)
23 (19)
27 (23)
23 (19)
29 (25)
32 (24)
20 (15)
40 (30)
25 (19)
18 (13)
48 (19)
43 (17)
67 (26)
48 (19)
47 (19)
Categorisation 
 Category 1* 95 (81) 107 (79) 202 (80)
Smear grading 
 1+
 2+
 3+
62 (53)
29 (25)
27 (23)
69 (51)
29 (21)
37 (27)
131 (52)
58 (23)
64 (25)
Duration of symptoms prior
  to TB diagnosis
 ⩽4 weeks
 >4–8 weeks
 ⩾9 weeks
46 (39)
37 (31)
35 (30)
88 (65)
25 (19)
22 (16)
134 (53)†
62 (25)
57 (23)
Patients aware of airborne route 
  of TB infection transmission 92 (78) 95 (70) 187 (73)
Patients aware that TB is 
  transmissible to other 
  family members 25 (21) 113 (84) 138 (55)‡
Patients aware that the mouth 
  should be covered 
  when coughing 104 (88) 128 (95) 232 (92)
* New smear-positive PTB. 
† Rural vs. urban, P < 0.01.
‡ Rural vs. urban, P < 0.001.
PTB = pulmonary tuberculosis.
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Excerpts from focus group discussions 
among health care workers
Awareness of IPT and RNTCP guidelines for 
contact management
Urban: HCWs were aware of both contact screening 
for TB and the recommendation to offer IPT to chil-
dren aged <6 years:
We refer the child contacts of smear-positive pa-
tients who are less than 6 years of age to the Gov-
ernment Children’s hospital for investigations be-
fore starting them on chemoprophylaxis. (HCWs)
Rural: there was general awareness that all con-
tacts with respiratory complaints have to be screened 
for TB. However, most HCWs were unaware of the 
need for IPT for child contacts aged <6 years.
If a child of a smear-positive patient is symptom-
atic, we ask them to take a chest X-ray in a private 
laboratory, and in case of doubt, refer them to a 
higher speciality centre for opinion, based on 
which we give treatment. We have not started any 
child on chemoprophylaxis so far. (The MO of 
one TU)
In the other TU, the MO said that the children 
were given IPT at the TU level.
Awareness of IPT administration 
Urban: the HCWs were aware that INH was to be 
given at a dosage of 5 mg/kg for chemoprophylaxis. 
Documentation and isoniazid administration
HCWs said that they entered the child’s name on the 
reverse side of the treatment card of the index case 
under the ‘Prophylaxis’ column. INH was issued to 
the index case on a monthly basis, with instructions 
to give the drug daily to the child. 
We ask the patient to report after the drug con-
tainer becomes empty and give him the next 
monthly supply. (HCWs)
No record was made of the drug supply: 
There is no provision for recording the supply of 
INH anywhere except what we do while account-
ing for the drug. (HCWs)
However, one HCW said: ‘I record the date of drug 
supply in a pocket diary and ask the patient to bring 
it along when he comes for drug collection.’
Ensuring drug intake
The HCWs said that when they supplied the INH to 
index cases they instructed them to give the drugs 
regularly to the child. They said, ‘There is no existing 
procedure to be followed to ensure drug intake or de-
fault retrieval.’ In addition, ‘Even if the index case 
defaulted, the family member came for collection of 
the drug for the child after the medicines were over.’
Periodic evaluation of the child on IPT
Children initiated on IPT are not periodically 
reviewed. 
We enquire about the child when the parent at-
tends for drug collection and ask them to bring 
the child for check-up in case of complaints. 
(HCWs)
Report of side effects to isoniazid
According to the HCWs, there were no reports of 
adverse effects.
Ensuring treatment completion
The date of starting IPT is entered on the index card 
by the HCWs. IPT administration ends with the com-
pletion of treatment in the index case. The comple-
tion date is also entered in the remarks column of the 
index case’s treatment card.
Rural: the MO from one rural study site was 
aware of the need for IPT administration. He said 
that children aged <6 years who are contacts of 
smear-positive patients are given a monthly supply 
of INH for 6 months after screening for TB at his pri-
mary health centre (PHC). However, he admitted that 
there was no periodic follow-up or mechanism for 
monitoring drug intake for these children. The other 
HCWs, including the MOs, were ignorant about IPT 
for child contacts aged <6 years.
Suggestions from HCWs
Urban: the HCWs felt that IPT implementation 
would be much easier if a separate card was provided 
for documentation. They said: ‘We have no provision 
for recording the drug supply and a separate card 
would be useful.’ They expressed their willingness to 
implement IPT if a detailed procedure and a separate 
card were provided. 
Table 2 Information on contact screening and IPT initiation 
from 253 interviewed smear-positive PTB patients
Characteristics
Rural
n (%)
Urban
n (%)
Total
n (%)
Contacts in the same house
Adults
Children aged ⩾6–14 years 
Children aged <6 years
299
 73
 51
308
 63
 33
607
136
 84
Patients who were informed by 
HCWs to screen all close contacts
for TB (n = 253)*  24 (20)  36 (27)  60 (24)
Children aged (0–14 years) screened 
for TB (n = 220)†  21 (17)  10 (10)  31 (14)
Patients who said that they were 
informed about the provision of IPT 
for children aged <6 years in their 
house (n = 55)‡   6 (18)   9 (41)  15 (27)
Children aged <6 years initiated on 
IPT (n = 84)§   7 (14)   9 (27)  16 (19)
* Rural (n =118) and urban (n = 135).
† Rural (n =124) and urban (n = 99).
‡ Rural (n =33) and urban (n = 22).
§ Rural (n = 51) and urban (n = 33).
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Rural: the MOs were willing to implement IPT in 
the future. However, the VHNs, who are the directly 
observed treatment (DOT) providers in rural areas, 
were reluctant to take the responsibility of providing 
IPT for the children. 
TB patients experience a lot of side effects and pa-
tients have also died due to jaundice. In case the 
child develops side effects with the drugs, it is dif-
fi cult to manage at the fi eld level and we will be 
blamed. (VHNs)
They felt that IPT for children should be adminis-
tered at the PHC or TU level, under the supervision 
of the MO or STS.
DISCUSSION
The study fi ndings suggest that RNTCP policies on 
child contact screening and IPT are not being effec-
tively implemented. Among those patients with young 
child contacts, only a quarter had been informed of 
the availability of IPT for these children; this is simi-
lar to fi ndings of a survey conducted in Malawi.6 This 
implies a lack of awareness among both HCWs and 
patients of the need to screen all close contacts and 
provide IPT for young children. Screening of young 
children living in the households of smear-positive 
PTB cases has identifi ed active TB disease in 22–34% 
(higher rates have been seen in high human immuno-
defi ciency virus [HIV] prevalent settings), and can 
contribute a signifi cant proportion of the total num-
ber of registered childhood cases of TB.3,4,7–10 A study 
from Morocco observed that the proportion of TB 
cases identifi ed in household contacts of registered 
TB cases was signifi cantly higher in children aged 
<10 years.11 Among child contacts (aged <5 years) 
of sputum-positive PTB patients, the proportion in-
fected ranged from 27.9% to 62.6% in various stud-
ies.4,8,9,12 The progression to disease is highest among 
infants, followed by children aged 1–5 years, subse-
quently decreasing in the age 5–10-year group and 
increasing again in adolescence.13 In addition, chil-
dren aged <5 years are at higher risk of developing 
disseminated forms of TB, including miliary disease 
and meningitis, which are frequently associated with 
greater morbidity and mortality. Moreover, studies 
have shown that young age and HIV infection are risk 
factors for more severe disseminated disease, with HIV 
infection increasing the risk of TB disease twenty 
fold.14 A comprehensive review of the natural history 
of childhood TB showed that primary infection be-
fore 2 years of age frequently progressed to serious 
disease within the fi rst 12 months, without signifi cant 
prior symptoms.15 However, for infants, the time span 
may be as short as 6–8 weeks.16 It is therefore impor-
tant that all child contacts of smear-positive PTB pa-
tients be screened for active TB.
The 19% rate of IPT initiation in child contacts in 
the present study is higher than the fi ndings of a Ma-
lawi survey, in which only 23 of 365 children aged 
<5 years received IPT.6 We found no documentary 
evidence of IPT completion rates, which further high-
lights the inadequate implementation of IPT services. 
Even where policies are being implemented, documen-
tation of the activities is weak. The FGDs revealed 
greater awareness of the policy on contact screening 
and IPT among HCWs at urban sites, highlighting 
the need for training of rural HCWs. The FGDs also 
suggested that contact screening and IPT could be 
implemented easily if detailed procedures and a sepa-
rate ‘patient’ card for the individual child were to be 
made available. The card would be a reminder for 
IPT and would help ensure accountability. 
Active screening and chemoprophylaxis of chil-
dren exposed to adult index cases are often neglected 
due to resource constraints and the high burden of 
adult TB. It is documented that a substantial propor-
tion of transmission in highly endemic areas, such as 
the study community, occurs outside the household, 
especially once children become mobile within the 
community.17 Nonetheless, the fact that the majority 
of transmission in children aged <3 years occurs in 
the household, and that this is the group at highest 
risk of progressing to disease following primary in-
fection, emphasises the importance of active contact 
tracing and the provision of IPT in high-risk chil-
dren.18 With a prevalence of INH resistance and of 
multidrug resistance among previously untreated 
PTB patients of respectively 15.4% and 3.4% in 
Tamil Nadu, the protective effi cacy of IPT among 
contacts of drug-resistant TB patients needs further 
evaluation.19 However, active tracing and screening 
of high-risk household contacts will also allow dis-
eased children to be diagnosed earlier, lessening 
complications.
In the present study, the duration of symptoms (di-
agnostic delay) was shorter and the knowledge that 
TB is transmissible was more frequent among urban 
patients. This reinforces the need to educate patients 
in rural area about the risk of transmission to family 
members and the symptoms of TB.
The situation observed in this study is likely to oc-
cur in other parts of India, as contact screening and 
IPT have not been prioritised by the RNTCP. IPT for 
young children is essential to limit the risk of pro-
gression to disease, especially its severe forms. Fur-
thermore, treating latent infection in childhood 
would reduce the pool from which infectious TB 
cases may later arise. It is now planned to pilot the 
implementation of the World Health Organization 
(WHO) guidelines for contact management in chil-
dren in two sites in Tamil Nadu, in order to develop 
detailed procedural and documentation mecha-
nisms.20 If found to be feasible and successful, these 
could be adopted by the RNTCP and scaled up across 
the country.
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R É S U M É
C O N T E X T E  :   Le Programme National Révisé de Lutte 
contre la Tuberculose (RNTCP) en Inde recommande de 
dépister pour une maladie tuberculeuse (TB) l’ensemble 
des contacts au sein du ménage des cas de tuberculose 
pulmonaire (TBP) à frottis positif et de soumettre les 
enfants asymptomatiques âgés de moins de 6 ans à un 
traitement préventif à l’isoniazide (IPT) pendant 6 mois.
O B J E C T I F  :   Evaluer la mise en œuvre du dépistage des 
enfants-contact et de l’administration de l’IPT dans le 
cadre du RNTCP.
M É T H O D O L O G I E  :   Etude transversale entre juillet et 
septembre 2008, menée dans quatre unités TB (TU) sé-
lectionnées au hasard, deux dans un site urbain (Chen-
nai City) et deux dans un site rural (district de Vellore) à 
Tamil Nadu, Inde du Sud. L’étude a comporté la lecture 
des cartes de traitement TB des cas-source (patients TBP 
à frottis positif mis sous traitement) nouveaux ou en re-
traitement, l’interview des cas-source et des discussions 
focalisées de groupe (FGD) chez les travailleurs de soins 
de santé.
R É S U LTAT S  :   Les interviews de 253 patients TB ont ré-
vélé que sur 220 contacts âgés de <14 ans, 31 seulement 
(14%) avaient été dépistés pour la TB ; sur les 84 enfants 
du ménage âgés de <6 ans, 16 seulement (19%) avaient 
été placés sous IPT. La documentation sur les détails des 
contacts faisait défaut dans les cartes de traitement des 
cas-source. Les FGD ont révélé une prise de conscience 
plus élevée chez les travailleurs de soins de santé urbains, 
mais un manque de procédures détaillées.
C O N C L U S I O N  :   La fourniture d’informations utilisant 
une carte d’IPT séparée et une formation focalisée peu-
vent aider à améliorer la mise en œuvre des activités de 
dépistage et d’IPT.
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M A R C O  D E  R E F E R E N C I A  :   En el Programa Nacional 
Revisado de lucha contra la Tuberculosis (RNTCP) en 
India, se recomienda la detección sistemática de la tu-
berculosis (TB) en todos los contactos domiciliarios de 
los casos con tuberculosis pulmonar (TBP) y bacilosco-
pia positiva y la administración de tratamiento preven-
tivo con isoniazida (IPT) durante 6 meses a los niños 
asintomáticos <6 años de edad.
O B J E T I V O  :   Evaluar la ejecución de la detección siste-
mática y la IPT a los niños, dentro del RNTCP.
M É T O D O S  :   Se llevó a cabo un estudio transversal en 
cuatro unidades de control de TB, dos en zona urbana 
(la ciudad de Chennai) y dos en zona rural (el distrito de 
Vellore) en Tamil Nadu, escogidas en forma aleatoria en 
el sur de la India entre julio y septiembre del 2008. El es-
tudio comprendió una revisión de las tarjetas de trata-
miento de los casos iniciales (pacientes con baciloscopia 
positiva nuevos o en retratamiento que habían comen-
zado una pauta terapéutica), entrevistas a estos pacien-
tes y reuniones en grupos de discusión (FGD) con los 
profesionales de la salud.
R E S U LTA D O S  :   Las entrevistas a 253 pacientes con TBP 
pusieron evidencia que de los 220 contactos <14 años, 
solo en 31 (14%) se practicó la detección sistemática de 
la TB ; de los 84 niños <6 años en los hogares, solo 16 
(19%) comenzaron la IPT. Las tarjetas de tratamiento 
de los casos iniciales carecían de información sobre los 
contactos. Los FGD con los profesionales de salud reve-
laron una mayor sensibilización en los centros urbanos, 
pero la falta de procedimientos detallados. 
C O N C L U S I Ó N  :   Es posible fomentar la ejecución de las 
actividades de la detección sistemática y la IPT mediante 
la provisión de documentación sobre el manejo de los 
contactos, el uso de una tarjeta exclusiva para el IPT y la 
capacitación específi ca.
R E S U M E N
